You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Harvard Business School
Moodys
Express Scripts
Boehringer Ingelheim

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Patent: 10,004,747

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,004,747
Title:Combination therapy
Abstract: The present invention relates to methods for treating and/or preventing metabolic diseases comprising the combined administration of a GLP-1 receptor agonist and a DPP-4 inhibitor.
Inventor(s): Klein; Thomas (Radolfzell, DE), Grempler; Rolf (Birkenhard/Warthausen, DE), Mark; Michael (Biberach an der Riss, DE)
Assignee: Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE)
Application Number:15/428,594
Patent Claims:see list of patent claims

Details for Patent 10,004,747

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Sanofi-aventis Us ADLYXIN lixisenatide SOLUTION;SUBCUTANEOUS 208471 002 2016-07-27   Start Trial Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) 2030-05-05 RX search
Sanofi-aventis Us ADLYXIN lixisenatide SOLUTION;SUBCUTANEOUS 208471 001 2016-07-27   Start Trial Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) 2030-05-05 RX search
Eli Lilly And Co TRULICITY dulaglutide INJECTABLE;INJECTION 125469 002 2015-03-09   Start Trial Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) 2030-05-05 RX search
Eli Lilly And Co TRULICITY dulaglutide INJECTABLE;INJECTION 125469 001 2015-03-09   Start Trial Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) 2030-05-05 RX search
Glaxosmithkline Llc TANZEUM albiglutide INJECTABLE;INJECTION 125431 001 2014-04-15   Start Trial Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) 2030-05-05 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 10,004,747

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
AstraZeneca
McKinsey
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.